Logo image of BHC.CA

BAUSCH HEALTH COS INC (BHC.CA) Stock Overview

Canada - TSX:BHC - CA0717341071 - Common Stock

9.01 CAD
-0.03 (-0.33%)
Last: 9/29/2025, 7:00:00 PM

BHC.CA Key Statistics, Chart & Performance

Key Statistics
52 Week High13.74
52 Week Low5.91
Market Cap3.33B
Shares369.80M
Float324.41M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)5.28
PE1.71
Fwd PE1.47
Earnings (Next)10-28 2025-10-28/bmo
IPO09-20 1994-09-20
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


BHC.CA short term performance overview.The bars show the price performance of BHC.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10

BHC.CA long term performance overview.The bars show the price performance of BHC.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of BHC.CA is 9.01 CAD. In the past month the price decreased by -11.32%. In the past year, price decreased by -20.27%.

BAUSCH HEALTH COS INC / BHC Daily stock chart

BHC.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TLRY.CA TILRAY BRANDS INC N/A 2.87B
CRON.CA CRONOS GROUP INC 59 1.58B
DHT-UN.CA DRI HEALTHCARE TRUST 6.98 827.85M
GUD.CA KNIGHT THERAPEUTICS INC N/A 589.93M
WEED.CA CANOPY GROWTH CORP N/A 585.44M
TSND.CA TERRASCEND CORP N/A 495.45M
ACB.CA AURORA CANNABIS INC N/A 487.13M
HITI.CA HIGH TIDE INC N/A 456.30M
CPH.CA CIPHER PHARMACEUTICALS INC 24.55 397.78M
OGI.CA ORGANIGRAM GLOBAL INC N/A 368.06M
NGEN.CA NERVGEN PHARMA CORP N/A 241.82M
XLY.CA AUXLY CANNABIS GROUP INC 5 202.24M

About BHC.CA

Company Profile

BHC logo image Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 20,700 full-time employees. Its comprehensive portfolio of over 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter (OTC) products and ophthalmic surgical devices and instruments. The Salix segment consists of sales in the U.S. of gastroenterology products. The International segment consists of sales, except for sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Diversified segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Bausch + Lomb segment includes Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products.

Company Info

BAUSCH HEALTH COS INC

2150 St. Elzear Blvd. West

Laval QUEBEC H7L 4A8 CA

CEO: Joseph C. Papa

Employees: 20700

BHC Company Website

BHC Investor Relations

Phone: 18003611448

BAUSCH HEALTH COS INC / BHC.CA FAQ

What is the stock price of BAUSCH HEALTH COS INC today?

The current stock price of BHC.CA is 9.01 CAD. The price decreased by -0.33% in the last trading session.


What is the ticker symbol for BAUSCH HEALTH COS INC stock?

The exchange symbol of BAUSCH HEALTH COS INC is BHC and it is listed on the Toronto Stock Exchange exchange.


On which exchange is BHC.CA stock listed?

BHC.CA stock is listed on the Toronto Stock Exchange exchange.


What is the price forecast or stock price prediction for BAUSCH HEALTH COS INC stock?

9 analysts have analysed BHC.CA and the average price target is 10.2 CAD. This implies a price increase of 13.21% is expected in the next year compared to the current price of 9.01. Check the BAUSCH HEALTH COS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BAUSCH HEALTH COS INC worth?

BAUSCH HEALTH COS INC (BHC.CA) has a market capitalization of 3.33B CAD. This makes BHC.CA a Mid Cap stock.


How many employees does BAUSCH HEALTH COS INC have?

BAUSCH HEALTH COS INC (BHC.CA) currently has 20700 employees.


What are the support and resistance levels for BAUSCH HEALTH COS INC (BHC.CA) stock?

BAUSCH HEALTH COS INC (BHC.CA) has a support level at 9 and a resistance level at 10.07. Check the full technical report for a detailed analysis of BHC.CA support and resistance levels.


Is BAUSCH HEALTH COS INC (BHC.CA) expected to grow?

The Revenue of BAUSCH HEALTH COS INC (BHC.CA) is expected to grow by 5.61% in the next year. Check the estimates tab for more information on the BHC.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BAUSCH HEALTH COS INC (BHC.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BAUSCH HEALTH COS INC (BHC.CA) stock pay dividends?

BHC.CA does not pay a dividend.


When does BAUSCH HEALTH COS INC (BHC.CA) report earnings?

BAUSCH HEALTH COS INC (BHC.CA) will report earnings on 2025-10-28, before the market open.


What is the Price/Earnings (PE) ratio of BAUSCH HEALTH COS INC (BHC.CA)?

The PE ratio for BAUSCH HEALTH COS INC (BHC.CA) is 1.71. This is based on the reported non-GAAP earnings per share of 5.28 and the current share price of 9.01 CAD. Check the full fundamental report for a full analysis of the valuation metrics for BHC.CA.


BHC.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to BHC.CA. When comparing the yearly performance of all stocks, BHC.CA is a bad performer in the overall market: 88.51% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BHC.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to BHC.CA. While BHC.CA is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BHC.CA Financial Highlights

Over the last trailing twelve months BHC.CA reported a non-GAAP Earnings per Share(EPS) of 5.28. The EPS increased by 3.55% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.99%
ROA 0.36%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%2.25%
Sales Q2Q%5.29%
EPS 1Y (TTM)3.55%
Revenue 1Y (TTM)7.13%

BHC.CA Forecast & Estimates

9 analysts have analysed BHC.CA and the average price target is 10.2 CAD. This implies a price increase of 13.21% is expected in the next year compared to the current price of 9.01.

For the next year, analysts expect an EPS growth of 5.02% and a revenue growth 5.61% for BHC.CA


Analysts
Analysts48.89
Price Target10.2 (13.21%)
EPS Next Y5.02%
Revenue Next Year5.61%

BHC.CA Ownership

Ownership
Inst Owners47.96%
Ins Owners10.81%
Short Float %N/A
Short RatioN/A